QIX Dividenden Europa 36658003 / DE000SLA3LM9
16’315.67
Pkt
-45.03
Pkt
-0.28
%
22:29:53
Anzeige
| Kurse + Charts + Realtime | Nachrichten | Listen | Info | zugeh. Wertpapiere | |
|---|---|---|---|---|---|
| Snapshot | Chart (gross) | Marktberichte | enthaltene Werte | GV-Termine | Strukturierte Produkte |
| Historisch | Chartvergleich | Analysen | Top/Flop | Dividenden | Trading-Depot |
| Marktkapitalisierung | |||||
Kurse + Charts + Realtime
Nachrichten
Info
zugeh. Wertpapiere
Analysen zu QIX Dividenden Europa-Werten
| 07.02.24 | TotalEnergies Buy | UBS AG | |
| 07.02.24 | Hannover Rück Sell | UBS AG | |
| 07.02.24 | Hannover Rück Buy | Jefferies & Company Inc. | |
| 07.02.24 | DHL Group Overweight | Barclays Capital | |
| 07.02.24 | Hannover Rück Overweight | JP Morgan Chase & Co. | |
| 07.02.24 | Hannover Rück Outperform | RBC Capital Markets | |
| 06.02.24 | Iberdrola Neutral | Goldman Sachs Group Inc. | |
| 06.02.24 | GSK Buy | UBS AG | |
| 06.02.24 | Hennes & Mauritz AB Neutral | UBS AG | |
| 05.02.24 | TotalEnergies Sector Perform | RBC Capital Markets | |
| 05.02.24 | GSK Buy | Deutsche Bank AG | |
| 05.02.24 | Roche Sell | Deutsche Bank AG | |
| 05.02.24 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
| 05.02.24 | Allianz Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.02.24 | Roche Neutral | UBS AG | |
| 02.02.24 | Hennes & Mauritz AB Neutral | UBS AG | |
| 02.02.24 | GSK Equal Weight | Barclays Capital | |
| 02.02.24 | Roche Kaufen | DZ BANK | |
| 02.02.24 | Roche Equal Weight | Barclays Capital | |
| 02.02.24 | Roche Sell | Deutsche Bank AG | |
| 02.02.24 | Siemens Buy | Deutsche Bank AG | |
| 02.02.24 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
| 02.02.24 | Mercedes-Benz Group Overweight | JP Morgan Chase & Co. | |
| 02.02.24 | Mercedes-Benz Group Outperform | Bernstein Research | |
| 01.02.24 | Hannover Rück Underweight | Barclays Capital | |
| 01.02.24 | GSK Halten | DZ BANK | |
| 01.02.24 | VINCI Buy | Jefferies & Company Inc. | |
| 01.02.24 | Roche Neutral | UBS AG | |
| 01.02.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 01.02.24 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. | |
| 01.02.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.02.24 | Hennes & Mauritz AB Sell | Deutsche Bank AG | |
| 01.02.24 | GSK Buy | Deutsche Bank AG | |
| 01.02.24 | GSK Buy | Deutsche Bank AG | |
| 01.02.24 | Roche Hold | Jefferies & Company Inc. | |
| 31.01.24 | Hennes & Mauritz AB Hold | Jefferies & Company Inc. | |
| 31.01.24 | Hennes & Mauritz AB Underperform | Bernstein Research | |
| 31.01.24 | Allianz Overweight | JP Morgan Chase & Co. | |
| 31.01.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 31.01.24 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets |